Your Source for Venture Capital and Private Equity Financings

Prologue Medicine Receives $50M Funding

2024-05-17
CAMBRIDGE, MA, Flagship Pioneering has committed $50 million to Prologue Medicines, a company unlocking the therapeutic potential of the viral proteome.
Flagship Pioneering, the bioplatform innovation company, unveiled Prologue Medicines, a company unlocking the therapeutic potential of the viral proteome for the creation of powerful new medicines. Flagship has initially committed $50 million to advance the company's Decoding Evolutionary Logic of Variant Ensembles (DELVE)™ Platform and harness its power to develop a pipeline of medicines for a wide range of diseases, with an initial focus in immunological, oncology and metabolic indications.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors